Finding Answers Through Collaboration
Published on in CHOP News
Unique endocrinology-neurology collaboration seeks to understand the variation in seizure activity in patients with hyperinsulinism/hyperammonemia.
Published on in CHOP News
Unique endocrinology-neurology collaboration seeks to understand the variation in seizure activity in patients with hyperinsulinism/hyperammonemia.
Published on in CHOP News
CHOP researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism.
Published on in CHOP News
Eighteen months ago, the Office of Endocrinology and Diabetes welcomed Rachel Walega to their team as a Clinical Research Project Manager. There, Rachel works on projects in Cystic Fibrosis related diabetes, Down syndrome and bone fragility.
Published on in CHOP News
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Published on in CHOP News
Diva De León-Crutchlow, MD, MSCE, assumed the role of Director of the Congenital Hyperinsulinism Center in 2013 and was named Chief of the Division of Endocrinology and Diabetes in 2018.
Published on in HI Hope
Parents are usually blindsided when they find out that their child has congenital hyperinsulinism (HI), a rare genetic disorder that depresses blood sugar to dangerously low levels.
Published on in HI Hope
Low blood sugar is one of the symptoms of Kabuki syndrome, a genetic disorder that affects multiple systems in the body but can be tricky to diagnose.
Published on in CHOP News
A pilot study at CHOP is the first to demonstrate the effectiveness of the bihormonal bionic pancreas in hyperinsulinism patients.
Published on in CHOP News
The landmark TODAY2 study found that those diagnosed with type 2 diabetes during childhood and adolescence have a high risk of developing serious health complications by early adulthood.
Published on in CHOP News
CARES Foundation has named CHOP as a Center for Excellence in Congenital Adrenal Hyperplasia.